Evidence map›Paper›PMID 41413565›Full record

ReviewMalaria journal2025

African leaders and regional institutions need to take the bull by the horns: a perspective on the impact of the 2025 funding cuts to malaria programmes.

Caroline B Osoro, Jenny Hill

Abstract readReview
In one paragraph

Review in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Caroline B OsoroPopulation and Health Impact Surveillance Group, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya. cosoro@kemri-wellcome.org.
Jenny HillDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite global malaria programmes already operating within resource constraints, 2025 saw a significant decrease in funding following the US government's termination of most of its global health programmes, as well as the decline in development aid spending by the UK, France, Germany, Canada, Switzerland, and other countries. The disruption of funding was sudden, with most African countries lacking adequate contingency plans. This, despite most of the malaria burden being in Africa (94% of 263 million cases in 2023), accounting for a reduction in gross domestic product of up to 1.3% annually, and half a billion lost workdays. Key malaria control programme activities have been severely impacted, including insecticide-treated bed net distribution, seasonal malaria chemoprevention campaigns, and malaria indicator surveys. In the wake of the funding cuts, some African governments have committed to increasing efforts to raise funds for malaria programmes from the private sector. The Africa Centres for Disease Control and Prevention (CDC) has developed a strategy for governments to increase health budgets while seeking additional funding from the private sector, all while maintaining transparency and accountability. If recent malaria control gains are to be sustained and to prevent resurgence across the continent, African governments will need to increase domestic funding and build robust public-private partnerships for their malaria programmes. Lessons can be learnt from countries where these partnerships have succeeded or failed. Leadership by the African Union, the Africa CDC, the African Leaders Malaria Alliance, and other regional bodies is crucial to support countries in taking immediate, substantive steps and benchmarking progress.

Indexed as

Communicable Disease ControlMalariaAfricaHumansAfricaGlobal healthHealth financingMalaria

Identifiers

PMID41413565
PMCPMC12794410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.